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1975-51 I Single-D~~elntramu~~uiarAdmini~tration~f
Extended-ReleareeAngiopeptinReducesin-Stent
Restenosis
M.K. Hong, K.M. Kent, F.O.Tie’, M.L. Foegh, S. Cathapermal,
R. Kornowski, O. Bramwall, M.B. Leon. Washington Hospital Center,
Washington, DC, USA, 1Univeraityof Texas,San Antonio, Texas,USA
Previously weahowedthat continuous S.C.Angio@ptin (AP) infusion for one-
week significantly reduces neointima formation by 40% in a porcine coronary
overstretch in-stent restenoais model. Due to the impractical nature of this
therapy, we evaluated the relative efficacy of various Ap formulations in the
aame model. 30 pigs (N = 10/group) were randomly assigned to: (Group 1)
controla receiving no AP; (Group 2) onetime i.m. treatment of 20 mg of AP;
and (Group3) continuous APoveraweekperiod viaas.c. osmotic pump (200
@kg total doae). One oversized Palmaz-Schatz stent (mean stenf/artery.
1.25)was implantsdinthe LAD followed by repeatangiography and histology
4 weeks later to evaluate the degree of in-stent neointima.
Group1 Gr0uP2 Gr0up3
%DS* 25& 17% 13+ s% 14+9°A
Neointima(mm2)** 1,65 +0.97 0.93+ 0.41 0.s5 * 0.2s
CM= diameter stenosis;*p= 0.072; ** p= 0.016 byANOVA.
Plaama AP ravealed comparable levels in both treatment groups, which
pereiated for up to 2 weeks. Cone/usiona:Single-dose i.m. extended-release
AP reduces in-atent restenosis as effectively as prolonged systemic S.C.
treatment. Thus, a practical, effective pharmamlogic therapy for preventing
in-stent restenosis may be available and should be evaluated in patients.
e] EXpre55iOnOfNOnmu.~,eMYosinHesWChsin-~
sfter BalloonAngioplastyin Atherosclerotic
Yucatan Micropigs
B.J.G.L. de Smet, H. de Leon, M.J. Post, Y.J. van der Helm, C. Beret,
J.N. Wilcox’. Heart Lung kratitute, LWecht,The Netherlands, 1.Enrory
University Atlanta, GA, USA
Nonmuscie myosin heavy chain-b isoform (nmmhc-b) is expreased by vas-
cular amooth muscle cells and because of its overexpression in restenotic
lesions nmmhc-b mma has been proposed as a potential therapeutic target.
This study wea deaigned to further examine the expression of nmmhc-
b after balloon angioplasty (BA) by in situ hybridization with 35S-labeled
nmmhc-b riboprobes in a combined denudation and atherogenic diet-induced
atherosclerosis model using Yucatan micropigs. 5’-bromo-2’-deoxyuridine
(brdu) was administered to detect proliferating cells. BA was performed in
iliac and femoral arteries and the arteries were examined 1, 2, 7 or 14 days
later. Contralateral arteries without BA were used as controls. Low expres-
sion of nmmhc-b mma was found in control atherosclerotic arteries in all
areas of the media and intima. Seven and 14 days after BA, nmmhc-b mrna
expression was markedly increased. At 7 days increased expression was
found predominantly in cells in the intima near the lumen and in medial and
adventitial cells near break-points of the internal elastic Iamina. Nmmhc-b
mrna expression at 14 days after BA showad almost the same pattern as
at 7 days. Cells expressing nmmhc-b mrna stained with a-actin or both w
actin and vimentin, but not with ceidesmon, suggesting that these cells were
smooth muscle and/or myofibroblasts. Nmmhc-b mrna expression was not
limited to brdu positive cells. These data suggest that nmmhc-b mrna is a
marker of dedifferentiation retherthan proliferation. However,the mechanism
by which nmmhc-b mrna plays a role in restenosis is still unclear.
1975-531EffactofEndova5cuiarStentDe5ign0n
Experimental Restenosis
E. Alt, J. Pasquantonio, T. Fliedner, M. Janczewski 1, K. Prietzel
W. Erhard 1, A. Stemberger 1, A. Schomig. 1 /. Med. K/ini/r, krst. for Exp
Surgery Tachnische Universit&VMiinchen, GermarrK Klinikum derlsarand
Deutsches Herzzentrum, TechnischeUniversit# Mtinchen, Germany
Background: Vascular interventions which maximize initial lumen diameter
provoke vascular response. Stent design influences vascular recoil, platelet
activation, thrombus formation, and stent induced vascular injwy, which all
determine restenosia. The goal of this study was to investigate the impact of
stent design on vaacular injury and restenosis.
Methods.’24 standard slotted tube stents (Palmez-Schatz) and laser cut
tube stents with a novel design (lnFlow Dynamics) wera randomly implanted
in the LAD or LCX of 12 swine with a balloen-to-vessel ratio of 1.4. The
novel stent has linked circumferential sinusoidal atruts with an oval strut
cross section, eliminating sharp edges and mrnere. Upon expansion the
stent opens symetricelly, without torqueing of the struts, thereby reducing
vessel injury.
r7esu/ts:There was no significant difference between the two stents with
reapect to metallic surface area, deployment balloon characteristics, poat-
procedural angiographic lumen diameter, or balloon-to-vessel ratio. After 30
days, the novel stent showed significantly less neointimal thickness (2S3 +
123VS460 + 174 #m, p < 0.05), less neointimal area (1.62+ 0.S6VS2.79 +
1.01 mmz, p = 0.05), and less lumen area Ioas (41.3% vs 57.6%, p < 0.05).
Conclusion: Vascular wall injury depending on stent deaign is one of
the factors responsible for restenosis. improved stent design can reduce
neointimal growth in the experimental model.
D97554 Effects of Sonicetion With Cathater-Deliverad LowFreauencv Ultrasound on Proliferation. Miaration
and ”Drug‘Uptake of Vascular Smooth Mue;le Cells
R. Kbster, C.W. Harem, W. Terres, J. K~hler, W. Steffen, H.-M. Stubbe,
T. Meinertz. Univereify Hospita/ Eppendorf, Dept. of Cardio/og~ Hamburg,
Germany
Catheter-delivered therapeutic ultrasound (US) ablates arteriosclerotic plaque
and dissolves thrombi. Ultrasound energy is transmitted mainly by acoustic
cavitation and vibration. After sonicetion, the majofity of medial smooth mus-
cle cells (SMC) remains histologically intact. To assess US-related functional
side effacts, we investigated proliferation, migration and drug uptake of SMC.
Methods: SMC were cultivated from human aortic tissue and sonicated
from a distanceof 2.0 mm through culture medium for 10, 30, 60 s. Cell
proliferation was measured by 3H-thymidine incorporation after 8, 16, 24
and 40 h. Migration of soniceted cella was determined by Boyden chamber
assay. Drug uptake into cells was aasessed using a fluorescence-labelled
oligodeoxynucleotide (ODN) (concentration range: 1–10 MM) after 4, 8 and
12 h. Cell viability was assessed by trypan blue exclusion.
Resu/ts: After sonication, cell viabiiity (98 + 2%) waa not significantly
diminished at the energy levels and application periods used. 3H-thymidina
inmrporetion into SMC was maximally reduced by 3S + 11% at 24 houra
peat intervention (p < 0.001); 40 h post intervention, proliferation rate of
US-treated cells returned to normal level. Migratory activity of SMC wee
maximally reduced by 28 + 9% (p = 0.05). ODN uptake of calla was not
significantly different between ultrasound treated cells and controls.
Conclusions: 1. Sonicetion with the US-device temporarily decreased
proliferation and migration of SMC. 2. The reduction of proliferation was
spontaneously and ~mpletely reversible, suggesting that no major intrecal-
Iular alteration occurred. 3. Sonication did not induce an enhanced cellular
uptake of ODN in vitro.
1975-551 NatriUreticPeP~ide RacePt~rEXPreSSiOn in the
Naointima at the Sita of Percutaneous Trensluminal
Coronary Angioplasty
T. Naruko, M. Lfeda, K. Haze, A.C. van der Wal, C.M. van der Loos,
A.E. Becker, Y. Fukuda, K. Kitano, H. Itoh. Oseka City Genera/ /-fospita/,
Osaka, Japan, Academic Medical Centec Amaterdam, The Netherianda
Restenosis after percutaneous transluminal coronary angioplasty (PTCA) is
considered due to neointimal proliferation and constrictive remodeling. Natri-
uretic peptides (NP) play a role in relaxation and growth inhibition of vascular
smooth muscle cells (SMCS);the effects depend on the presence of speoffic
receptors (NPR). Hence, NP could be involved in both mechanisms that
underlie restenoais. To test this hypothesis, we studied immunocytochemi-
cally the expression of NPR during the peat-PTCA healing process, Sixteen
sites (5 days-24 months after PTCA) were studied, all obtained at autopsy.
Frozen sections were ateined with monoclinal antibodies against human
NPR-A, NPR-B, and NPR-C, SMCS, macrophages, and endothelial cells.
In post-PTCA sites from 1 to 2 months, most neointimal SMCS expressed
NPR-A; its expression decreased from 6 months onward. NPR-B expression
in neointimal SMCSwas found at 1 month after PTCA only. in contrast, NPR-
C was strongly express~ always in the neointimal SMCS at 1-24 months
after PTCA. The expression of the receptors NPR-A and NPR-B early after
PTCA suggests an antiproliferative action of NP. The long-term and strong
expression of the clearance receptor, NPR-C, within tha neointima at the site
of PTCA may counteract vasorelaxation thus indicating vessel wall constric-
tion. These findings strongly suggest a pathophysioiogical role for NPR-C in
the development of constrictive remodeling after PTCA.
